DelistingJul 2, 2026, 08:32 AM
RenovoRx Gets Nasdaq Extension for Minimum Bid Price
AI Summary
RenovoRx, Inc. received a notification from Nasdaq granting an additional 180-day period to regain compliance with the $1.00 minimum bid price requirement. The new deadline for compliance is December 28, 2026. The company had previously received a deficiency notice on December 31, 2025, with an initial compliance period ending on June 30, 2026. If compliance is not met by the new deadline, the common stock may be delisted from Nasdaq.
Key Highlights
- Nasdaq granted RenovoRx an additional 180-day period to regain compliance.
- The new deadline to meet the minimum bid price requirement is December 28, 2026.
- Company previously received a deficiency notice on December 31, 2025.
- Original compliance period ended on June 30, 2026.
- Compliance requires a closing bid price of at least $1.00 for 10 consecutive business days.
Price Impact
More from RNXT